CORC  > 湖南大学
A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer
Lu Yang; Yun Li; Arup Bhattacharya; Yuesheng Zhang
刊名Science Translational Medicine
2019
卷号Vol.11 No.476页码:eaav1620
ISSN号1946-6234;1946-6242
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4736805
专题湖南大学
作者单位1.Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
2.Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
3.Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
推荐引用方式
GB/T 7714
Lu Yang,Yun Li,Arup Bhattacharya,et al. A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer[J]. Science Translational Medicine,2019,Vol.11 No.476:eaav1620.
APA Lu Yang,Yun Li,Arup Bhattacharya,&Yuesheng Zhang.(2019).A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer.Science Translational Medicine,Vol.11 No.476,eaav1620.
MLA Lu Yang,et al."A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer".Science Translational Medicine Vol.11 No.476(2019):eaav1620.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace